AMM207-62
[Monoclonal Antibody]
AKT1 Mouse Monoclonal Antibody
www.yhsbio.com
market@yhsbio.com
support@yhsbio.com
+86-21-54651191
Room 703,Building 6,333# Guiping
Rd.,Xuhui District,Shanghai,China
DATASHEET
Species: |
Mouse |
Applications: |
WB ELISA |
Immunogen Range: |
A purified recombinant fragment of human AKT1 expressed in E. Coli |
Clonality: |
Monoclonal Antibody |
Isotype: |
IgG1 |
GENE ID: |
207/208/10000 |
Swiss Prot: |
P31749/P31751/Q9Y243 |
Synonyms: |
EC 2.7.11.1RAC-PK-alphaProtein kinase BPKBC-AKT/EC 2.7.11.1RAC-PK-betaProtein kinase Akt-2Protein kinase B, betaPKB beta/EC 2.7.11.1RAC-PK-gammaProtein kinase Akt-3Protein kinase B, gammaPKB gammaSTK-2 |
Purification: |
Affinity chromatography |
Storage: |
Store at -20°C or -80°C in PBS with 0.02% sodium azide and 50% glycerol. Avoid freeze/thaw cycles. |
Background: |
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. |
Caculated MW: |
56 kDa |
Observed MW: |
Refer to Figures |
Applications: |
WB 1:500-1:2000
|
Reacitivity: |
Human, Monkey, Mouse |
For research use only. Not intended for diagnostic or therapeutic use!